US Patent Issued to Vanda Pharmaceuticals on March 24 for "Treatment of lower respiratory tract infection with tradipitant" (Maryland, Virginia Inventors)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,582,640, issued on March 24, was assigned to Vanda Pharmaceuticals Inc. (Washington).

"Treatment of lower respiratory tract infection with tradipitant" was invented by Mihael H. Polymeropoulos (Potomac, Md.), Christos Polymeropoulos (Potomac, Md.), Vasilios Polymeropoulos (Potomac, Md.) and Changfu Xiao (Vienna, Va.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein is a method of treatment of a lower respiratory tract infection caused by, e.g., coronavirus disease (COVID-19), influenza, or other virus, comprising treatment with the NK-1 receptor antagonist, tradipitant."

The patent was filed on March 24, 2021, under Application No. 17/90...